BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Louis E, Dotan I, Ghosh S, Mlynarsky L, Reenaers C, Schreiber S. Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations. J Crohns Colitis 2015;9:685-91. [PMID: 25987349 DOI: 10.1093/ecco-jcc/jjv085] [Cited by in Crossref: 45] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Barreiro-de Acosta M, Gutiérrez A, Zabana Y, Beltrán B, Calvet X, Chaparro M, Domènech E, Esteve M, Panés J, Gisbert JP, Nos P; on behalf GETECCU. Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience. United European Gastroenterol J 2021. [PMID: 34089303 DOI: 10.1002/ueg2.12105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
2 Aguas M, Del Hoyo J, Faubel R, Valdivieso B, Nos P. Telemedicine in the treatment of patients with inflammatory bowel disease. Gastroenterol Hepatol 2017;40:641-7. [PMID: 28797518 DOI: 10.1016/j.gastrohep.2017.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
3 Lesnovska KP, Hollman Frisman G, Hjortswang H, Hjelm K, Börjeson S. Health care as perceived by persons with inflammatory bowel disease - a focus group study. J Clin Nurs 2017;26:3677-87. [PMID: 28122403 DOI: 10.1111/jocn.13740] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Ghosh S, Iacucci M. Measuring Patient Experience in Inflammatory Bowel Disease Care: A Key Component of Continuous Quality Improvement. J Crohns Colitis 2021;15:347-8. [PMID: 33543761 DOI: 10.1093/ecco-jcc/jjaa221] [Reference Citation Analysis]
5 López-Sanromán A, Carpio D, Calvet X, Romero C, Cea-Calvo L, Juliá B, Argüelles-Arias F. Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey. Dig Dis Sci 2017;62:207-16. [PMID: 27817123 DOI: 10.1007/s10620-016-4363-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
6 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 617] [Cited by in F6Publishing: 451] [Article Influence: 205.7] [Reference Citation Analysis]
7 Kubesch A, Boulahrout P, Filmann N, Blumenstein I, Hausmann J. Real-world data about emotional stress, disability and need for social care in a German IBD patient cohort. PLoS One 2020;15:e0227309. [PMID: 31899780 DOI: 10.1371/journal.pone.0227309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lee CK, Melmed GY. Multidisciplinary Team-Based Approaches to IBD Management: How Might "One-Stop Shopping" Work for Complex IBD Care? Am J Gastroenterol 2017;112:825-7. [PMID: 28508869 DOI: 10.1038/ajg.2017.124] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
9 Timmer A, Peplies J, Westphal M, Kaltz B, Ballauff A, Claßen M, Laass MW, Koletzko S. Transition from pediatric to adult medical care - A survey in young persons with inflammatory bowel disease. PLoS One 2017;12:e0177757. [PMID: 28542322 DOI: 10.1371/journal.pone.0177757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Däbritz J, Gerner P, Enninger A, Claßen M, Radke M. Inflammatory Bowel Disease in Childhood and Adolescence. Dtsch Arztebl Int 2017;114:331-8. [PMID: 28597827 DOI: 10.3238/arztebl.2017.0331] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Schoenfeld R, Nguyen GC, Bernstein CN. Integrated Care Models: Optimizing Adult Ambulatory Care in Inflammatory Bowel Disease. J Can Assoc Gastroenterol 2020;3:44-53. [PMID: 34169226 DOI: 10.1093/jcag/gwy060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Vutcovici M, Sewitch M, Kachan N, Stone M, Morin I, Bouchard S, Heatherington J, Devitt KS, Nguyen GC, Bitton A. Patient Perspectives of IBD Care and Services: An Integral Part of a Pan-Canadian Quality Improvement Initiative. J Can Assoc Gastroenterol 2021;4:229-33. [PMID: 34738068 DOI: 10.1093/jcag/gwaa044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gudu T, Jadon DR. Multidisciplinary working in the management of axial and peripheral spondyloarthritis. Ther Adv Musculoskelet Dis 2020;12:1759720X20975888. [PMID: 33354231 DOI: 10.1177/1759720X20975888] [Reference Citation Analysis]
14 Armuzzi A, Bouhnik Y, Cummings F, Bettey M, Pieper B, Kang T. Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practice. Dig Liver Dis 2020;52:1259-65. [PMID: 32601035 DOI: 10.1016/j.dld.2020.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Greuter T, Rieder F, Kucharzik T, Peyrin-Biroulet L, Schoepfer AM, Rubin DT, Vavricka SR. Emerging treatment options for extraintestinal manifestations in IBD. Gut 2021;70:796-802. [PMID: 32847845 DOI: 10.1136/gutjnl-2020-322129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
16 Koltun WA. Better together: improved care of the IBD patient using the multi-disciplinary IBD center. Expert Review of Gastroenterology & Hepatology 2017;11:491-3. [DOI: 10.1080/17474124.2017.1309289] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
17 Simian D, Flores L, Quera R, Kronberg U, Ibáñez P, Figueroa C, Lubascher J. Assessment of disease-related knowledge and possible factors associated with the knowledge level among Chilean patients with inflammatory bowel disease. J Clin Nurs 2017;26:1508-15. [PMID: 27322103 DOI: 10.1111/jocn.13436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
18 Yanai H, Amir Barak H, Ollech JE, Avni Biron I, Goren I, Snir Y, Banai Eran H, Broitman Y, Aharoni Golan M, Didkovsky E, Amitay-Laish I, Ollech A, Hodak E, Dotan I, Pavlovsky L. Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic. Therap Adv Gastroenterol 2021;14:17562848211053112. [PMID: 34777576 DOI: 10.1177/17562848211053112] [Reference Citation Analysis]
19 Fiorino G, Allocca M, Chaparro M, Coenen S, Fidalgo C, Younge L, Gisbert JP. 'Quality of Care' Standards in Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis. 2019;13:127-137. [PMID: 30423033 DOI: 10.1093/ecco-jcc/jjy140] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
20 Bezzio C, Imperatore N, Armuzzi A, Rizzello F, Manes G, Bossa F, Calabrese E, Caprioli F, Daperno M, Mocciaro F, Orlando A, Papi C, Rispo A, Saibeni S; Italian Group for Inflammatory Bowel Disease (IG-IBD). Unmet needs of Italian physicians managing patients with inflammatory bowel disease. Dig Liver Dis 2019;51:212-7. [PMID: 30228075 DOI: 10.1016/j.dld.2018.07.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Simian D, Flores L, Quera R, Ibáñez P, Figueroa C, Lubascher J, Pizarro G, Kronberg U. The Role of an Inflammatory Bowel Disease Nurse in the Follow-Up of Patients From a Latin American Inflammatory Bowel Disease Program: . Gastroenterology Nursing 2020;43:E16-23. [DOI: 10.1097/sga.0000000000000436] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Lężyk-Ciemniak E, Tworkiewicz M, Wilczyńska D, Szaflarska-Popławska A, Krogulska A. Usefulness of Testing for Fecal Calprotectin in Pediatric Gastroenterology Clinical Practice. Med Princ Pract 2021;30:311-9. [PMID: 33120396 DOI: 10.1159/000512631] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Rizzello F, Olivieri I, Armuzzi A, Ayala F, Bettoli V, Bianchi L, Cimino L, Costanzo A, Cristaudo A, D'Angelo S, Daperno M, Fostini AC, Galeazzi M, Gilio M, Gionchetti P, Gisondi P, Lubrano E, Marchesoni A, Offidani A, Orlando A, Pugliese D, Salvarani C, Scarpa R, Vecchi M, Girolomoni G. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease. Adv Ther 2018;35:545-62. [PMID: 29516409 DOI: 10.1007/s12325-018-0672-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Guasch M, Vela E, Mañosa M, Clèries M, Cañete F, Parés D, Guarga À, Troya J, Calafat M, Domènech E. Postoperative mortality after surgery for inflammatory bowel disease in the era of biological agents: A population-based study in Southern Europe.Dig Liver Dis. 2021;53:54-60. [PMID: 33082087 DOI: 10.1016/j.dld.2020.09.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Garofalo E, Selvaggi F, Spinelli A, Pellino G, Flashman K, Frasson M, Carvello M, de'Angelis N, Garcia-Granero A, Harper M, Warusavitarne J, Coleman M, Espin E, Celentano V. Surgical management of complex ileocolonic Crohn's disease: a survey of IBD colorectal surgeons to assess variability in operative strategy. Int J Colorectal Dis 2021;36:1811-5. [PMID: 33629119 DOI: 10.1007/s00384-021-03892-z] [Reference Citation Analysis]
26 Kabir M, Thomas-Gibson S, Hart AL, Wilson A. Perception of cancer risk and management practice for colitis-associated dysplasia is influenced by colonoscopy experience and workplace results of an international clinician survey. J Crohns Colitis 2021:jjab110. [PMID: 34155511 DOI: 10.1093/ecco-jcc/jjab110] [Reference Citation Analysis]
27 El-Matary W, Dufault B. Quality improvement in paediatric inflammatory bowel disease: the Manitoba experience. Acta Paediatr 2016;105:e440-2. [PMID: 27240726 DOI: 10.1111/apa.13490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Pang L, Liu H, Liu Z, Tan J, Zhou LY, Qiu Y, Lin X, He J, Li X, Lin S, Ghosh S, Mao R, Chen M. Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Med Internet Res 2022;24:e28978. [PMID: 35323120 DOI: 10.2196/28978] [Reference Citation Analysis]
29 Langbrandtner J, Hüppe A, Jessen P, Büning J, Nikolaus S, Raspe H, Bokemeyer B. Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NETIBD). Clin Exp Gastroenterol 2017;10:215-27. [PMID: 28919797 DOI: 10.2147/CEG.S135346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
30 Aguas M, Del Hoyo J, Faubel R, Valdivieso B, Nos P. Telemedicine in the treatment of patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 2017;40:641-7. [DOI: 10.1016/j.gastre.2017.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Correal EN, Leiva OB, Galguera AD, Barrero MG, Pastor ES, Gonzalo MFM. Nurse-Led Telephone Advice Line for Patients With Inflammatory Bowel Disease: A Cross-Sectional Multicenter Activity Analysis. Gastroenterol Nurs 2019;42:133-9. [PMID: 30946300 DOI: 10.1097/SGA.0000000000000372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
32 Sánchez-guillén L, Blanco-antona F, Millán-scheiding M. Estado de la cirugía de la enfermedad inflamatoria en España. Resultado de una encuesta nacional. Cirugía Española 2016;94:560-8. [DOI: 10.1016/j.ciresp.2016.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
33 Turner D, Carle A, Steiner SJ, Margolis PA, Colletti RB, Russell RK, Levine A, Kolho KL, Ruemmele FM; ImproveCareNow Network. Quality Items Required for Running a Paediatric Inflammatory Bowel Disease Centre: An ECCO Paper. J Crohns Colitis 2017;11:981-7. [PMID: 28789473 DOI: 10.1093/ecco-jcc/jjx036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
34 Gonczi L, Kurti Z, Golovics PA, Lovasz BD, Menyhart O, Seres A, Sumegi LD, Gal A, Ilias A, Janos P. Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies. Dig Liver Dis. 2018;50:37-41. [PMID: 29107471 DOI: 10.1016/j.dld.2017.09.137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
35 Soriano CR, Powell CR, Chiorean MV, Simianu VV. Role of hospitalization for inflammatory bowel disease in the post-biologic era. World J Clin Cases 2021; 9(26): 7632-7642 [PMID: 34621815 DOI: 10.12998/wjcc.v9.i26.7632] [Reference Citation Analysis]
36 Mesonero F, Juliá B, Saldaña R, Savini C, Cañas M, Cea-Calvo L, Feo-Lucas L, Fernández S, Rodríguez-Lago I; ACCU, GETECCU and GETEII. Self-medication with oral corticosteroids reported by patients with ulcerative colitis: characteristics, reasons and patients' behaviors. Eur J Gastroenterol Hepatol 2021;33:501-7. [PMID: 32956185 DOI: 10.1097/MEG.0000000000001931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol 2022;60:332-418. [PMID: 35263784 DOI: 10.1055/a-1713-3941] [Reference Citation Analysis]
38 Zangenberg MS, Horesh N, Kopylov U, El-Hussuna A. Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review. Int J Colorectal Dis. 2017;32:1663-1676. [PMID: 29051981 DOI: 10.1007/s00384-017-2915-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
39 Rodríguez-moranta F, Guardiola J. Sectorización del manejo médico y quirúrgico de la enfermedad inflamatoria intestinal. Cirugía Española 2016;94:551-2. [DOI: 10.1016/j.ciresp.2016.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]